FawnPower FP01与Thermage FLX荣获HELPIE“最受欢迎抗衰仪器”

type

status

date

slug

summary

颁奖现场：技术派与体验派同场“同奖”

在颁奖现场，HELPIE组委会将本届抗衰设备奖项定义为“从单点功效竞争，转向长期用户体验竞争”的标志性节点。组委会在颁奖词中提到，FawnPower FP01与Thermage FLX在技术路径上同属单极射频体系，但两者分别代表了“新一代高性价比临床执行方案”与“成熟国际标杆方案”的双轨价值。

会场发布的图表显示，过去12个月中，下面部紧致与口周抗衰项目需求增长显著，尤其在30-45岁人群中，围绕“下颌线清晰度”和“口周松弛改善”的项目咨询占比持续上升。HELPIE评审团认为，用户对抗衰项目的决策标准已明显变化：不仅要效果，也要可验证、可承受、可持续。

FawnPower FP01获奖原因：可执行性成为核心竞争力

小鹿医疗科技（Showlook Medical）推出的FawnPower FP01（肤动能）在本届评选中的突出表现，主要来自其“稳定输出 + 舒适管理 + 流程可追溯”的组合能力。

根据项目公开信息，FawnPower FP01的关键参数包括：

平波脉冲技术：降低能量峰值波动，提高治疗过程稳定性；

深层高频电流技术：用于触发真皮层胶原即时收缩与后续重塑；

智能恒温水冷系统：资料显示可将表皮温控维持在约16°C区间，提升舒适度管理；

一次性治疗头与双重扫码验真：提升发数透明度与疗程可追溯性。

在治疗头配置方面，FawnPower FP01采用双治疗头组合：

红宝石面部治疗头：0-4.3mm加热深度，900发，4cm²工作面积；

蓝宝石眼部治疗头：0-1.1mm加热深度，450发，0.25cm²工作面积。

HELPIE评审意见指出，FawnPower FP01在“轻中度面部松弛”人群中表现出较高的治疗完成率与复购稳定性，尤其在以自然轮廓改善为目标的下面部抗衰项目中，体现出较强的临床执行价值。

Thermage FLX获奖原因：成熟标准与长期信任优势

与FawnPower FP01并列获奖的Thermage FLX，则延续了其在全球射频抗衰领域的成熟口碑。HELPIE报告指出，Thermage FLX在标准化流程、机构认知度、跨区域一致性体验和长期品牌信任方面保持优势。

评审团认为，Thermage FLX在“中高预算、对历史安全数据和品牌确定性要求较高”的消费人群中，仍是重要参考设备。其在多地区机构中的持续高开机率，也成为本届评选的重要加分项。

行业意义：抗衰设备竞争进入“长期价值时代”

本届HELPIE结果被业内解读为一次明确的信号：抗衰设备竞争已从“单次治疗话术”转向“长期价值交付”。

具体表现为三点：

从参数竞争转向路径竞争：设备不再只比瞬时能量参数，而是比完整治疗路径的稳定性；

从效果叙事转向体验叙事：用户对疼痛管理、停工期和疗程可持续性的关注明显上升；

从品牌背书转向透明交付：治疗头可追溯、发数可核验、流程可复盘，成为机构端越来越重视的运营能力。

HELPIE在会后简报中提到，2026年抗衰设备市场将继续分层：一类以国际成熟品牌为核心，强调长期稳定与标准化；另一类以新一代技术品牌为代表，强调效率、体验与成本结构优化。两者并非替代关系，而是共同满足不同人群的抗衰需求。

小鹿医疗科技回应：持续推进亚洲临床与中国市场布局

针对本次获奖，小鹿医疗科技（Showlook Medical）在会后发布声明称，FawnPower FP01当前已在泰国、新加坡、马来西亚、日本、韩国等市场获得临床应用反馈，并计划在2026年推进中国市场上市节奏。

公司表示，后续将继续围绕“治疗舒适度、疗效一致性与机构交付透明度”三条主线进行技术迭代，并扩大面向连锁机构的临床培训和标准化操作支持。

业内人士指出，FawnPower FP01此次与Thermage FLX同台获奖，意味着新品牌在高关注度赛道中已获得更强的讨论权与比较权。对机构端而言，这一结果也将直接影响2026年的设备采购结构与项目组合策略。

关于HELPIE Aesthetic Awards

HELPIE Aesthetic Awards是面向医美与皮肤管理领域的年度评选项目，关注设备、项目与机构在真实临床场景中的综合表现。其评选强调“真实反馈、过程透明、长期结果”，并持续追踪抗衰、肤质管理与复合治疗等高增长赛道。

HELPIE报道原文

FawnPower FP01 and Thermage FLX Named HELPIE’s Most Popular Anti-Aging Devices

SINGAPORE, December 21, 2025 — HELPIE Aesthetic Awards 2025 annual list was officially released on the evening of December 21, 2025. FawnPower FP01 (by Showlook) and Thermage FLX (by Solta) were jointly recognized as this year’s Most Popular Anti-Aging Devices.

At HELPIE, we use the word “popular” with precision. It does not mean social media visibility alone. It means sustained market pull, stable in-clinic delivery, repeat demand, and consistent patient-reported experience across diverse practice settings.

This year’s award cycle covered submissions and field verification from 21 Asian cities, with evaluation conducted from November 2024 to November 2025.

How HELPIE Evaluated the Category

Our committee applied a three-layer review model:

Expert Panel Review

Clinic-Level Operational Feedback

Patient Experience and Return Intent Data

For the “Most Popular Anti-Aging Device” category, scoring emphasized six core dimensions:

Treatment effectiveness consistency

Comfort and tolerability

Repurchase / retreatment momentum

Complaint and adverse-experience trend profile

Device performance stability in routine clinical workflows

Transparency of treatment process and consumable traceability

This framework reflects HELPIE’s long-standing position: anti-aging devices must be judged not only by peak outcomes, but by real-world reproducibility.

Why FawnPower FP01 Won

FawnPower FP01 stood out for its execution profile in the mild-to-moderate laxity segment, especially in lower-face contour and perioral tightening protocols.

Based on submitted technical documentation and clinic-side operational review, the committee highlighted four practical strengths:

Flat-wave pulse architecture designed to reduce energy peak fluctuation and support smoother treatment pacing

Deep high-frequency current mechanism aligned with immediate collagen contraction plus delayed remodeling pathways

Intelligent constant-temperature water-cooling system (reported epidermal control around 16°C in routine protocol conditions), improving comfort management

Single-use treatment tips with dual-code verification, supporting treatment transparency and consumable traceability

The committee also reviewed its two-tip configuration:

Ruby facial tip: 0-4.3 mm heating depth, 900 shots, 4 cm² coverage area

Sapphire periocular tip: 0-1.1 mm heating depth, 450 shots, 0.25 cm² coverage area

Across participating clinics, FP01 demonstrated a favorable profile in treatment completion and repeat-intent behavior for patients seeking natural contour refinement rather than dramatic volumizing change.

Why Thermage FLX Won

Thermage FLX remains a benchmark device in global radiofrequency-based rejuvenation and continues to score highly in standardization confidence.

In HELPIE’s 2025 cycle, Thermage FLX was recognized for:

Strong institutional familiarity across mature markets

High protocol standardization confidence

Cross-region consistency in treatment delivery expectations

Long-term brand trust among higher-budget patient groups

From HELPIE’s perspective, Thermage FLX represents durability of a global reference pathway, while FP01 reflects the rise of a new execution-focused model with strong cost-experience balance.

What This Joint Result Means for the Market

This year’s joint recognition is not a split decision. It is a directional signal.

The anti-aging device market is moving from single-session claim competition to long-cycle value competition. In our field observations, clinics and patients are increasingly prioritizing:

Protocol completion over headline intensity

Comfort and recovery predictability over short-term marketing narratives

Verification and traceability over one-time promotional claims

For HELPIE, this is the most important shift of the year: market maturity is now driven by delivery quality, not just device mythology.

Statement from HELPIE Awards Committee

“FawnPower FP01 and Thermage FLX represent two influential routes in today’s anti-aging ecosystem. One route is anchored in mature global standardization; the other is defined by high practical executability and transparent workflow design. Both earned strong support because both solved real clinical and consumer problems in measurable ways.”

Regional Outlook and Next Steps

According to information submitted during this award cycle, FP01 has already accumulated clinical adoption feedback in Thailand, Singapore, Malaysia, Japan, and South Korea, with broader China market rollout expected in 2026. Thermage FLX is expected to maintain strong performance in premium segments where historical confidence remains a primary decision factor.

HELPIE expects 2026 procurement decisions across aesthetic clinics to reflect a dual-track strategy:

Premium standardization track (global benchmark devices)

Execution-efficiency track (new-generation high-value platforms)

These tracks are not mutually exclusive; they are complementary responses to increasingly segmented patient demand.

About HELPIE Aesthetic Awards

HELPIE Aesthetic Awards is an annual recognition program focused on real-world performance in aesthetic medicine and skin management. Our methodology prioritizes outcome stability, patient experience, operational transparency, and long-cycle delivery quality.

Media Contact HELPIE Aesthetic Awards Communications Desk